Download Free Sample Report

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
This report aims to provide a comprehensive presentation of the global market for Liposomes for Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes for Drug Delivery. This report contains market size and forecasts of Liposomes for Drug Delivery in global, including the following market information:

• Global Liposomes for Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
• Global Liposomes for Drug Delivery Market Sales, 2018-2023, 2024-2029, (Tons)
• Global top five Liposomes for Drug Delivery companies in 2022 (%)

The global Liposomes for Drug Delivery market was valued at US$ 3431.8 million in 2022 and is projected to reach US$ 4211.1 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
We surveyed the Liposomes for Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Liposomes for Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Type, 2022 (%)

• Liposome Vitamin
• Liposome Ceramide
• Liposome CoQ10
• Others

Global Liposomes for Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, by Application, 2022 (%)

• Hydrophilic Drugs
• Hydrophobic Drugs

Global Liposomes for Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Liposomes for Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Liposomes for Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Liposomes for Drug Delivery revenues share in global market, 2022 (%)
Key companies Liposomes for Drug Delivery sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Liposomes for Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Lipoid Kosmetik
• Lucas Meyer Cosmetics
• Nippon Fine Chemical
• Enoc Solutions
• Nanovec
• Lipotec
• Croda
• H&A Pharmachem
• Lipomize
• ID bio
• BioSpectrum
• Derma Clinical
• Kewpie Corporation
• Nanohealth Biotech
• Creative Biostructure
• Phenbiox
• NOF CORPORATION
• KYOWA PHARMA CHEMICAL
• Nikko Chemicals

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Liposomes for Drug Delivery, market overview.
• Chapter 2: Global Liposomes for Drug Delivery market size in revenue and volume.
• Chapter 3: Detailed analysis of Liposomes for Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Liposomes for Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Liposomes for Drug Delivery capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.